Procaps Group (Procaps Group) Days Sales Outstanding : 98.41 (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Procaps Group Days Sales Outstanding?

Procaps Group's average Accounts Receivable for the three months ended in Sep. 2023 was $127.7 Mil. Procaps Group's Revenue for the three months ended in Sep. 2023 was $118.4 Mil. Hence, Procaps Group's Days Sales Outstanding for the three months ended in Sep. 2023 was 98.41.

The historical rank and industry rank for Procaps Group's Days Sales Outstanding or its related term are showing as below:

PROC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 83.42 Med: 98.26 Max: 108.41
Current: 103.43

During the past 4 years, Procaps Group's highest Days Sales Outstanding was 108.41. The lowest was 83.42. And the median was 98.26.

PROC's Days Sales Outstanding is ranked worse than
75.7% of 996 companies
in the Drug Manufacturers industry
Industry Median: 71.41 vs PROC: 103.43

Procaps Group's Days Sales Outstanding increased from Sep. 2022 (88.56) to Sep. 2023 (98.41).

Procaps Group Days Sales Outstanding Historical Data

The historical data trend for Procaps Group's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Procaps Group Days Sales Outstanding Chart

Procaps Group Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Days Sales Outstanding

108.41

100.60

83.42

95.91

Procaps Group Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Days Sales Outstanding	Get a 7-Day Free Trial											88.56	101.34	119.44	95.19	98.41

Competitive Comparison of Procaps Group's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Procaps Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Procaps Group's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Procaps Group's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Procaps Group's Days Sales Outstanding falls into.

Procaps Group Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Procaps Group's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

	Days Sales Outstanding (A: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (101.041	+	114.391)	/	2 )	/	409.92	*	365
=	107.716					/	409.92	*	365
=	95.91

Procaps Group's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

	Days Sales Outstanding (Q: Sep. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Sep. 2023 ))	/	count )	/	Revenue (A: Sep. 2023 )	*	Days in Period
=	( (123.681	+	131.709)	/	2 )	/	118.41	*	365 / 4
=	127.695					/	118.41	*	365 / 4
=	98.41

Procaps Group (NAS:PROC) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Procaps Group Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Procaps Group's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Procaps Group (Procaps Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Procaps Group SA (NAS:PROC) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

9X1:Germany

Address

9 Rue de Bitbourg, Luxembourg, LUX, L-1273

Website

https://www.procapsgroup.com

Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.

Executives

Alexandre Weinstein Manieu	director, 10 percent owner	CHASHAM PLACE, FLAT 1, LONDON X0 SW1X 8HG
Ruben Minski	director, 10 percent owner, officer: Chief Executive Officer	9 RUE DE BITBOURG, C/O PROCAPS GROUP, S.A., LUXEMBOURG N4 L-1273
Jose Minski	director, 10 percent owner	9 RUE DE BITBOURG, C/O PROCAPS GROUP, S.A., LUXEMBOURG N4 L-1273
Sognatore Trust	10 percent owner	OFICINA 503A-02, EDIFICIO QUANTUM, (500) RUTA 8 KM. 17.500 ZONAMERICA, MONTEVIDEO X3 91600
Simphony Trust	10 percent owner	29 BANCROFT MILLS ROAD, WILMINGTON DE 19806
Deseja Trust	10 percent owner	29 BANCROFT MILLS ROAD, WILMINGTON DE 19806
Hoche Partners Pharma Holding S.a.	10 percent owner	3A VAL SAINTE CROIX, LUXEMBOURG N4 L-1371